Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lei Z et al. – Combined analysis of both studies shows a strong association of this four–marker haplotype with decreased NSCLC risk. This is the first evidence of an association between a TGFBR1 haplotype and risk for NSCLC.

Related Articles

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
British Journal of Cancer, 11/30/09    Relevance Score: 70%

Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial
BJU International, 11/25/09    Relevance Score: 70%

Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor
Oncogene, 11/19/09    Relevance Score: 70%

Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
The Journal of Nuclear Medicine, 11/17/09    Relevance Score: 70%

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/12/09    Relevance Score: 70%

Today in Basic Science/Genetics...keeping you current

The Role of Platelet and Fibrin Ultrastructure in Identifying Disease Patterns
Pathophysiology of Haemostasis and Thrombosis, 12/14/09

Regulation of ADAMTS13 Expression in Proliferating Human Umbilical Vein Endothelial Cells
Pathophysiology of Haemostasis and Thrombosis, 12/14/09

Nattokinase-Promoted Tissue Plasminogen Activator Release from Human Cells
Pathophysiology of Haemostasis and Thrombosis, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address